| The influence of nutrition on intestinal permeability and the microbiome in health and disease O Inczefi, P Bacsur, T Resál, C Keresztes, T Molnár Frontiers in Nutrition 9, 718710, 2022 | 59* | 2022 |
| Endoscopic postoperative recurrence in Crohn’s disease after curative ileocecal resection with early prophylaxis by anti-TNF, vedolizumab or ustekinumab: a real-world … H Yanai, A Kagramanova, O Knyazev, J Sabino, S Haenen, GJ Mantzaris, ... Journal of Crohn's and Colitis 16 (12), 1882-1892, 2022 | 44 | 2022 |
| Functional anatomical changes in ulcerative colitis patients determine their gut microbiota composition and consequently the possible treatment outcome A Bálint, K Farkas, O Méhi, B Kintses, BM Vásárhelyi, E Ari, C Pál, ... Pharmaceuticals 13 (11), 346, 2020 | 25 | 2020 |
| Double stenting for malignant biliary and duodenal obstruction: a systematic review and meta-analysis A Fábián, R Bor, N Gede, P Bacsur, D Pécsi, P Hegyi, B Tóth, Z Szakacs, ... Clinical and Translational Gastroenterology 11 (4), e00161, 2020 | 15 | 2020 |
| Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn’s disease … P Bacsur, M Matuz, T Resál, P Miheller, T Szamosi, E Schäfer, P Sarlós, ... Therapeutic Advances in Gastroenterology 15, 17562848221144349, 2022 | 10 | 2022 |
| Real-life efficacy of tofacitinib in various situations in ulcerative colitis: a retrospective worldwide multicenter collaborative study T Resál, P Bacsur, C Keresztes, A Bálint, R Bor, A Fábián, B Farkas, ... Inflammatory Bowel Diseases 30 (5), 768-779, 2024 | 8 | 2024 |
| Endoscopic ultrasound in the lower gastrointestinal tract A Fábián, R Bor, Z Bősze, T Tóth, P Bacsur, A Bálint, K Farkas, T Resál, ... Orvosi Hetilap 164 (30), 1176-1186, 2023 | 5 | 2023 |
| Evaluation of the Effectiveness and Safety of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease: An International Real‐Life Retrospective Multicentre Cohort Study P Bacsur, D Shaham, Z Serclova, T Resál, B Farkas, P Sarlós, P Miheller, ... Alimentary Pharmacology & Therapeutics 61 (2), 335-345, 2025 | 4 | 2025 |
| Plasminogen activator inhibitor 1 is a novel faecal biomarker for monitoring disease activity and therapeutic response in inflammatory bowel diseases B Jójárt, T Resál, D Kata, T Molnár, P Bacsur, V Szabó, Á Varga, ... Journal of Crohn's and Colitis 18 (3), 392-405, 2024 | 4 | 2024 |
| Risk Factors and Interpretation of Inconclusive Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology in the Diagnosis of Solid Pancreatic Lesions R Bor, B Vasas, A Fábián, M Szűcs, Z Bősze, A Bálint, M Rutka, K Farkas, ... Diagnostics 13 (17), 2841, 2023 | 3 | 2023 |
| Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls P Bacsur, M Rutka, A Asbóth, T Resál, K Szántó, B Jójárt, A Bálint, E Ari, ... Therapeutic Advances in Gastroenterology 16, 17562848231174298, 2023 | 3 | 2023 |
| Appendiceal mucinous neoplasm appearance on NBI colonoscopy P Bacsur, T Resál, K Farkas, S Ábrahám, T Molnár Journal of Gastrointestinal and Liver Diseases 31 (3), 270-270, 2022 | 3 | 2022 |
| A Crohn-betegég terápiás stratégiája K Farkas, H Székely, P Bacsur, B Bánky, ZB Élthes, L Harsányi, ... Orvosi Hetilap 165 (Supplement-1), 1-36, 2024 | 2 | 2024 |
| Accuracy of the Pancolonic Modified Mayo Score in predicting the long-term outcomes of ulcerative colitis: a promising scoring system P Bacsur, P Wetwittayakhlang, T Resál, E Földi, B Vasas, B Farkas, ... Therapeutic Advances in Gastroenterology 17, 17562848241239606, 2024 | 2 | 2024 |
| Infection risk related to gastrointestinal endoscopic procedures during the SARS-CoV-2 pandemic A Fábián, R Bor, T Tóth, P Bacsur, A Bálint, K Farkas, Á Milassin, T Molnár, ... Orvosi hetilap 163 (46), 1814-1822, 2022 | 2 | 2022 |
| Comparison of risk of malignancy and predictive value of diagnostic categories defined by Papanicolaou Society of Cytopathology system and WHO reporting system for … B Vasas, A Fábián, Z Bősze, S Hamar, L Kaizer, T Tóth, P Bacsur, T Resál, ... Therapeutic Advances in Gastroenterology 17, 17562848241271958, 2024 | 1 | 2024 |
| Long-term outcomes after endoscopic removal of malignant colorectal polyps: Results from a 10-year cohort A Fábián, R Bor, B Vasas, M Szűcs, T Tóth, Z Bősze, KJ Szántó, P Bacsur, ... World Journal of Gastrointestinal Endoscopy 16 (4), 193, 2024 | 1 | 2024 |
| P938 Effectiveness and safety of switching from original infliximab to GP1111 biosimilar in inflammatory bowel diseases–prospective, cohort study T Resál, P Bacsur, M Pápista, D Kata, B Farkas, A Bálint, A Fábián, R Bor, ... Journal of Crohn's and Colitis 18 (Supplement_1), i1706-i1707, 2024 | 1 | 2024 |
| Experience of switching vedolizumab treatment from intravenous to subcutaneous formulation in Hungary. P Bacsur, Á Iliás, T Resál, D Kata, T Molnár, K Farkas Alimentary Pharmacology & Therapeutics 58 (2), 2023 | 1 | 2023 |
| Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone T Resál, K Mangó, P Bacsur, K Szántó, D Pigniczki, C Keresztes, M Rutka, ... Expert Opinion on Drug Safety 22 (6), 517-524, 2023 | 1 | 2023 |
Klaudia FarkasUniversity of SzegedDirección de correo verificada de med.u-szeged.hu
